Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 37Thoracic 28CNS 18Sarcoma 5Other hematologic neoplasm 3Tumor-Agnostic 2Lymphoid 2Endocrine 2Plasma cell 1Other solid neoplasm 1Myeloid 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Retinoblastoma 1Retinal Neoplasms 1Eye Neoplasms 1

Interventions

pembrolizumab 26Pemetrexed 26Cisplatin 25Nivolumab 22Carboplatin 16Paclitaxel 14Gemcitabine 12Ipilimumab 11tislelizumab 8durvalumab 8Ramucirumab 8Docetaxel 8talazoparib 7Fluorouracil 7Radiotherapy 6Capecitabine 6tremelimumab 5cobimetinib 5atezolizumab 5adavosertib 5Radiosurgery 5Cyclophosphamide 5Bevacizumab 5olaparib 4avelumab 4Temozolomide 4Sunitinib 4Specimen Handling 4Platinum 4PM 01183 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Topotecan × Other solid neoplasm × Clear all
NCT00186888 2025-09-04

Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma

St. Jude Children's Research Hospital

Phase 3 Completed
107 enrolled 34 charts
Other solid neoplasm

Eye Neoplasms, Retinoblastoma, Retinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡